Tag: drug pricing
Rolling out CAR T across Europe
![4 EAPM09 Prof Christine Chomienne talking about CAR T implementation challenges during the 7th EAPM Presidency Conference in Brussels WEBSITE IMAGE](/assets/Uploads/4-EAPM09-Prof-Christine-Chomienne-talking-about-CAR-T-implementation-challenges-during-the-7th-EAPM-Presidency-Conference-in-Brussels-WEBSITE-IMAGE__ScaleMaxWidthWzY0MF0.jpg)
Patient-centric treatments such as gene and cell therapies have been a game-changer in tackling hematological disorders. Nonetheless, their development remains slow and erratic, limiting benefit for patients.
Dutch scientists propose algorithm to keep drugs affordable and accessible
![Formule video](/assets/Uploads/Formule-video__ScaleMaxWidthWzY0MF0.jpg)
The paper, titled ‘Sustainability and affordability of cancer drugs: a novel pricing model’ and written by Professor Carin Uyl-de Groot and Professor Bob Lӧwenberg from Erasmus University Rotterdam in the Netherlands, proposes an algorithm that should be used to determine innovative drug prices with ‘a maximum level of transparency’.